You are viewing the site in preview mode
Skip to main content
| How do you define IFs in clinical ES? |
| What kind of IFs do you report, firstly, from the laboratory to the clinician and, secondly, from the clinician to the patient? |
| What do you think about the intentional search for SFs? |
| What kind of policy regarding IFs and SFs would you like to develop? |
| What difficulties do you experience in your practice and (future) policy regarding IFs and SFs? |
| How is the possibility of IFs addressed during genetic counselling? |
| What might affect a patient’s interest in IFs and SFs? |
| What is your policy regarding a patient’s possibility to opt out of IFs? |
| How would you define a patient’s role in the context of IFs and SFs? How does this role relate to your professional role? |
| What impact might a reported IF or SF have on patients? |
| To what extent do you consider a personalised policy concerning IFs and SFs appropriate and feasible? |
- Abbreviations used: IF(s) Incidental finding(s); SF(s) Secondary finding(s); ES Exome sequencing
